Home / Medicine / аллергоферон бета

аллергоферон бета

Recorded active ingredients: Betamethasone Dipropionate, Interferon alfa-2b

Based on a snapshot of pillintrip.com listings. Country listings do not confirm current availability or registration. Sources and limitations · How matching works.

Countries

Medicines with the same recorded active ingredients

These listings match the full ingredient set recorded for аллергоферон бета. Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.

Pharmacy sales terms

According to the recipe.

Pharmacotherapeutic group

  • Glucocorticosteroid for topical use Cytokine [Glucocorticosteroids in combinations]
  • Glucocorticosteroid for topical use cytokine [Ophthalmic agents in combinations]

Special precautions for storage

At a temperature of 2-8 °C.

Keep out of reach of children.

The shelf life of the drug Allegation® beta2 года. Вскрытый флакон хранить не более 30 дней.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Eye and nasal drops 1 ml
active ingredients:  
betamethasone sodium phosphate 1 mg
interferon alpha-2b human recombinant at least 5000 IU
excipients: benzalkonium chloride-0.1 mg, disodium edetate dihydrate-0.5 mg, sodium chloride-3.2 mg, hypromellose-3 mg, potassium dihydrophosphate-3.63 mg, sodium hydrophosphate dodecahydrate-7.13 mg, povidone 8000-5 mg, macrogol 4000-30 mg, macrogol 400-10 mg, purified water-up to 1 ml  
Release form

Eye drops and nasal drops. In a plastic bottle with a dropper dispenser, 5 or 10 ml. 1 fl. in a pack of cardboard.

Nosological classification (ICD-10)

  • H10. 1 Acute atopic conjunctivitis
  • J30 Vasomotor and allergic rhinitis
  • J30. 1 Allergic rhinitis caused by plant pollen

Dosage (Posology) and method of administration

Conjunctival, intranasal.

With allergic conjunctivitis of moderate severity in the acute stage: instillation into the conjunctival sac of each eye 1 drop 3 times a day, followed by a decrease in the multiplicity (the number of injections per day), depending on the therapeutic effect.

With allergic rhinitis of moderate severity in the acute stage: instill in each nasal passage 2 drops 3 times a day, with a gradual decrease in the multiplicity (the number of injections per day), depending on the therapeutic effect.

The duration of treatment is 10 days.

ATC - Anatomical and therapeutic chemical classification

S01BA06 Betamethasone

Listed in 1 countries